Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Recruiting

2022-502968-20-02 Behcet's disease 4 2024-05-30
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A Recruiting

2023-507348-35-00 Risk for Type 1 Diabetes 6 2024-05-30
Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS-… Recruiting

2023-505929-14-00 Systemic Lupus Erythematosus 5 2024-05-21
Locally Advanced or Metastatic Hepatocellular Carcinoma: Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination with Budiga… Recruiting

2023-504600-28-00 Metastatic Hepatocellular Carcinoma (HCC) 10 2024-05-09
Therapeutic approach in Colchicine-resistant Recurrent pEricarditis in children: an open-label randomized trial comparing Anakinra vs sTEroi… Recruiting

2023-504756-96-00 Recurrent pericarditis, idiopathic or secondary to inva 5 2024-03-22
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adul… Recruiting

2023-504863-17-00 1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic 5 2024-02-21
eGPA and local inflammation within the ENT area Recruiting

2023-508029-28-00 Eosinophilic Granulomatosis with Polyangiitis (eGPA) 6 2024-02-13
Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults with Active Sjögren’s Syndrome Recruiting

2023-503327-26-00 Sjogren's syndrome 5 2024-01-31
A study to test how effective belumosudil tablets are for treating adult participants with chronic lung allograft dysfunction Recruiting

2023-503462-23-00 Lung transplant rejection 5 2023-12-28
Study comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid l… Recruiting

2023-504555-27-00 Myelodysplastic syndrome (MDS) 5 2023-11-28
For patients with active multiple sclerosis, impact of annual versus semi-annual infusions of ocrelizumab after 2 years of initial treatment… Recruiting

2023-505420-62-00 Multiple sclerosis 5 2023-11-09
Expression-linked and R-ISS-adapted stratification for first line therapy in multiple myeloma patients (ELIAS) Recruiting

2022-500453-16-00 Multiple Myeloma 4 2023-10-30
Hidradenitis Suppurativa: Evaluation of Upadacitinib in Adult and Adolescent Subjects Recruiting

2023-503661-28-00 Hidradenitis Suppurativa 5 2023-10-26
A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATO Recruiting

2022-501057-36-00 ANCA-associated vasculitis 5 2023-10-24
A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) … Recruiting

2022-502160-20-00 Idiopathic Immune Complex Mediated Membranoproliferativ 5 2023-10-02
A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematologic… Recruiting

2023-505357-40-00 Hematological cancer 5 2023-09-18
HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod… Recruiting

2023-504661-23-00 Antiphospholipid antibodies 5 2023-06-27
Early phase study to evaluate the safety and efficacy of SMART101 to improve transplantation in blood cancers Recruiting

2024-517953-28-00 Treatment in haematopoietic stem cell transplantation 7 2023-06-07
Desensitisation with imlifidase prior to kidney transplant in highly sensitised children Recruiting

2022-500230-28-00 Highly sensitised paediatric patients with a positive c 4 2023-06-02
12-month study of probiotic effects in non-infectious uveitis treatment Recruiting

2024-517946-32-00 Non-infectious uveitis 4 2023-06-02
Targeted therapy with anakinra for dilated cardiomyopathy: phase IIa randomized double blind monocentric clinical trial to evaluate the effi… Recruiting

2024-514861-21-00 Inflammatory dilated cardiomyopathy 4 2023-05-25
Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function or APhIRI II Recruiting

2024-515480-66-01 End stage kidney disease - Kidney transplantation donor 4 2023-05-22
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-1) Recruiting

2022-500699-76-00 Active Systemic Lupus Erythematosus (SLE) 5 2023-05-18
Imlifidase in ANCA-associated Vasculitis Recruiting

2024-516727-13-00 Anti-neutrophil cytoplasmic antibody (ANCA) associated 4 2023-05-17